Edwards Lifesciences Corporation Payments for Restructuring
Edwards Lifesciences Corporation (EW) reported Payments for Restructuring of $3.50 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsForRestructuring · last filed 2026-08-04
- Edwards Lifesciences Corporation payments for restructuring for the quarter ending 2026-06-30 was $1.60M, a 56.76% decline year-over-year.
- Edwards Lifesciences Corporation payments for restructuring for the quarter ending 2026-03-31 was $1.90M, a 68.85% decline year-over-year.
- Edwards Lifesciences Corporation payments for restructuring for the quarter ending 2025-12-31 was $6.40M.
- Edwards Lifesciences Corporation payments for restructuring for the quarter ending 2025-09-30 was $3.70M.
- Edwards Lifesciences Corporation payments for restructuring for fiscal 2025 was $19.90M, a 55.47% increase from fiscal 2024.
- Edwards Lifesciences Corporation payments for restructuring for fiscal 2024 was $12.80M.
| Period end | Payments for Restructuring 3 month | Payments for Restructuring 6 month | Payments for Restructuring 9 month | Payments for Restructuring 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $3.50M 10-Q · filed 2026-08-04 | $9.90M derived: sum of 3 quarters · filed 2026-08-04 | $13.60M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $1.90M 10-Q · filed 2026-05-06 | $8.30M derived: sum of 2 quarters · filed 2026-05-06 | $12.00M derived: sum of 3 quarters · filed 2026-05-06 | $15.70M derived: sum of 4 quarters · filed 2026-05-06 |
| 2025-12-31 | $6.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $10.10M derived: sum of 2 quarters · filed 2026-02-25 | $13.80M derived: sum of 3 quarters · filed 2026-02-25 | $19.90M 10-K · filed 2026-02-25 |
| 2025-09-30 | $3.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $7.40M derived: sum of 2 quarters · filed 2025-11-05 | $13.50M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $3.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $9.80M 10-Q · filed 2025-08-06 | ||
| 2025-03-31 | $6.10M 10-Q · filed 2025-05-06 | |||
| 2024-12-31 | $12.80M 10-K · filed 2026-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |